Sergio Traversa, Director at Actinium Pharmaceuticals, Inc. (ATNM), bought 3,000 shares at $2.02 ($6K) on 2016-04-15, disclosed to the SEC on 2016-04-18.
Open-market purchase of $6k ATNM by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.02 | 2,000 | $4K | 66.7% |
| 2 | $2.02 | 1,000 | $2K | 33.3% |
| Total | $2.02 avg | 3,000 | $6K | 100% |
| Filing → |
| RLMD | BUY | 2025-11-06 | $600K | — | Filing → |
| RLMD | BUY | 2025-08-28 | $265K | — | Filing → |
| RLMD | BUY | 2025-05-20 | $335K | — | Filing → |